On May 13, 2026, Frank Damelio, Director at Zoetis Inc ZTS, purchased 6,650 shares of the company, as reported in the SEC Filing. Following this transaction, the insider now owns a total of 21,458 shares of Zoetis Inc.
Zoetis Inc is a global leader in the animal health industry, dedicated to discovering, developing, manufacturing, and commercializing a diverse portfolio of animal health medicines and vaccines designed to meet the needs of veterinarians and livestock farmers.
The insider transaction history for Zoetis Inc indicates that there have been three insider buys and two insider sells over the past year. Over the same period, Frank Damelio has purchased a total of 6,650 shares and has not sold any shares.
On the day of the recent purchase, shares of Zoetis Inc were trading at $75.39, giving the stock a market cap of $31.165 billion. The company's price-earnings ratio stands at 12.33, which is lower than the industry median of 22.045 and also below the company's historical median price-earnings ratio.
With a trading price of $75.39 and a GF Value of $192.36, Zoetis Inc has a price-to-GF-Value ratio of 0.39, indicating that the stock is significantly undervalued based on its GF Value.
The GF Value is an intrinsic value estimate developed by GuruFocus, calculated based on historical multiples such as price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow. It also considers a GuruFocus adjustment factor based on the company's past returns and growth, along with future estimates of business performance from Morningstar analysts.
This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
